Onconova Therapeutics

Onconova Therapeutics is a clinical-stage biopharmaceutical company focused on discovering and developing new products for cancer patients. The company possesses proprietary targeted anticancer agents designed to disrupt specific cellular pathways critical to cancer cell proliferation.Onconova's novel proprietary multi-kinase inhibitor ON 123300 is being evaluated in two separate yet complementary Phase I dose escalation and expansion studies. These trials are currently ongoing in the United States and China.